Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Immediate Normal Saline Infusion for Stroke After Intravenous Thrombolysis (NS-STAR)

NCT05993078 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.

NCT NCT05993078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05993078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Immediate Normal Saline Infusion for Stroke After Intravenous Thrombolysis (NS-STAR)
Lead sponsor
Tianjin Medical University General Hospital
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2023
Completion date
January 8, 2025
Enrollment
241 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain infarct